| 601 | BADON, TY ALLENDURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT ONCOLOGY · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-21 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 602 | MOTT, AMANDA GRASHOFDURHAM, NC · 27701 | ACCESS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-21 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 603 | BOBBA, DURGA PRASADPHILADELPHIA, PA · 19104 | VP, VACCINE COMMERCIALISATION LEAD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-21 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 604 | CLOUD, MONICA RWASHINGTON, DC · 20004 | DIRECTOR FEDERAL GOVERNMENT RELATIONS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-21 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 605 | BAGCHI, INDRANILCOLLEGEVILLE, PA · 19426 | VP, GLOBAL PRICING & MARKET ACCESS HEA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-21 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 606 | FINNEGAN, CANDICE CINNAMONPHILADELPHIA, PA · 19112 | HEAD, STATE GOVERNMENT AFFAIRS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-21 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 607 | RIVIERE, JESSICAPHILADELPHIA, PA · 19104 | U.S. PATIENT ADVOCACY & ENGAGEMENT ENT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-03-21 | $100 | Primary (P) | Filing 1883819FEC filing ↗ |
| 608 | ABSHIRE, JIMNEWTON UPPER FALLS, MA · 02464 | DIRECTOR · GLAXO SMITH KLINE | VOTE SAVE AMERICAC00835587 | 2025-03-28 | $100 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1909485FEC filing ↗ |
| 609 | STEVENS, BENJAMINPHOENIXVILLE, PA · 19460 | CMC · GSK | MAD 4 PA PACC00670844 | 2025-03-29 | $100 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1903117 · amendedFEC filing ↗ |
| 610 | ENDRES, JENNEAN MARIEPHILADELPHIA, PA · 19104 | LAWYER/ATTORNEY · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-04-04 | $100 | Primary (P) | Filing 1891938FEC filing ↗ |
| 611 | FOX, JENNIFER WILLISDURHAM, NC · 27709 | MARKET ACCESS FIELD VICE PRESIDENT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-04-04 | $100 | Primary (P) | Filing 1891938FEC filing ↗ |
| 612 | MADAUSS, KEVIN PATRICKCOLLEGEVILLE, PA · 19426 | GENERAL PROJECT MANAGEMENT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-04-04 | $100 | Primary (P) | Filing 1891938FEC filing ↗ |
| 613 | LEWIS, ANTON DDURHAM, NC · 27709 | FVP, MARKET ACCESS ACCOUNT INTEGRATION · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-04-04 | $100 | Primary (P) | Filing 1891938FEC filing ↗ |
| 614 | THEVENET, PHILIP M.WASHINGTON, DC · 20004 | DIRECTOR, GOVERNMENT RELATIONS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-04-04 | $100 | Primary (P) | Filing 1891938FEC filing ↗ |
| 615 | BENEN, SANDRA E.DURHAM, NC · 27709 | DIRECTOR SGA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-04-04 | $100 | Primary (P) | Filing 1891938FEC filing ↗ |
| 616 | HOWELL, WILLIAM BDURHAM, NC · 27709 | SR SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-04-04 | $100 | Primary (P) | Filing 1891938FEC filing ↗ |
| 617 | HILL, WANDAPHILADELPHIA, PA · 19112 | GAPP SPECIAL PROJECTS - SECONDMENT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-04-04 | $100 | Primary (P) | Filing 1891938FEC filing ↗ |
| 618 | MARTIN, LISAPHILADELPHIA, PA · 19112 | CHIEF PROCUREMENT OFFICER · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-04-04 | $100 | Primary (P) | Filing 1891938FEC filing ↗ |
| 619 | BADON, TY ALLENDURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT ONCOLOGY · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-04-04 | $100 | Primary (P) | Filing 1891938FEC filing ↗ |
| 620 | MOTT, AMANDA GRASHOFDURHAM, NC · 27701 | ACCESS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-04-04 | $100 | Primary (P) | Filing 1891938FEC filing ↗ |